Clinical Trials Browser

Phase 1/2 × INDUSTRY × racemetyrosine × Clear all

NCT02562612 2022-07-01

Study of SM-88 in Advanced Cancers

Phase 1/2 Withdrawn

Breast Neoplasms

NCT02796898 2019-07-22

Study of the Efficacy, Safety, and Pharmacokinetics of SM88 in Patients With Prostate Cancer

Phase 1/2 Completed

Prostatic Neoplasms